SS-31 Is a Novel Mitochondrial-Targeted Therapy That Crosses Blood-Brain Barrier
Mitochondria play a vital role in cellular metabolism. Because of their widespread effects on cellular functions, mitochondrial dysfunction is implicated in a wide range of diseases. As such, mitochondria, the tiny energy factories found in most cells, are prime targets for drug development. But developing mitochondria-targeted drugs has been a daunting task.